Hepatitis viruses and human immunodeficiency virus (HIV) co-infection: pathogeny and treatments
Explore this paper's citation graph
- Type
- article
- Published
- 2004-05-01
- Cited by
- 0
- References
- 0
- OpenAlex
- https://openalex.org/W4255640712
Keywords
Medicine, Hepatitis C virus, Immunology, Hepatitis C, Hepatitis B virus
References
No references recorded for this paper.
Cited by
No citing papers recorded for this paper.
Related papers
- Failure of hepatitis C therapy in HIV-coinfected drug users is not due to a shift in hepatitis C virus genotype.
- Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels.
- Direct antiviral agents (DAAs) ‐ A new age in the treatment of hepatitis C virus infection
- Treatment of hepatitis C virus in the coinfected patient.
- Evidence for involvement of MHC restrictive mechanisms in hepatitis C virus (HCV) infection and HCV associated liver disease in renal transplant patients
- The detection of hepatitis C virus in South Hungary.
- Liver Disease in Injection Drug Users with Hepatitis C, With and Without HIV Coinfection
- Oxidative stress and nutritional factors in hepatitis C virus-positive liver recipients, controls, and hepatitis C virus-positive nontransplant patients.
- Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.
- Incidence and spontaneous clearance of hepatitis C virus (HCV) in people who inject drugs at the Stockholm Needle Exchange—Importance for HCV elimination